Profound Medical Ratios (2023-2025) | PROF

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 65.22%65.54%61.34%49.23%60.18%63.64%63.14%70.93%70.70%73.18%74.32%
EBT Margin 359.84%456.93%320.95%-2,434.54%-454.83%-309.00%-324.44%-135.37%-407.59%-706.97%-148.53%
EBIT Margin 367.63%401.75%379.63%-2,413.39%-547.39%-351.19%-317.73%-199.83%-426.02%-624.42%-168.52%
EBITDA Margin 367.63%401.75%379.63%-2,413.39%-524.95%-330.90%-310.06%-165.59%-405.23%-587.16%-166.10%
Operating Margin 367.63%401.75%379.63%-2,413.39%-547.39%-351.19%-317.73%-199.83%-426.02%-624.42%-168.52%
Net Margin 357.26%454.74%319.91%-2,420.21%-457.61%-309.85%-330.69%-133.17%-409.16%-709.86%-150.82%
FCF Margin 313.06%319.54%-1,517.48%-364.81%-314.73%-278.50%-241.03%-140.78%-316.02%-621.62%-181.77%
Efficiency
Inventory Average 6.30M7.57M8.35M
Assets Average 28.43M53.62M47.20M50.50M53.37M45.79M56.06M65.55M55.27M45.99M
Equity Average 55.61M45.02M35.70M
Invested Capital 38.33M65.08M55.28M43.72M36.62M
Asset Utilization Ratio 0.150.130.140.190.190.180.210.31
Leverage & Solvency
Interest Coverage Ratio 35.6133.5233.13-43.76-43.33-70.30
Debt to Equity 0.230.080.090.110.14
Debt Ratio 0.10M0.130.110.160.080.080.080.070.070.090.11
Equity Ratio 0.710.860.830.790.76
Times Interest Earned 35.6133.5233.13-43.76-43.33-70.30
Valuation
Enterprise Value -484.98M-39.27M-33.62M-26.21M-46.52M-34.08M-27.12M-54.91M-46.43M-35.20M-24.83M
Return Ratios
Return on Sales 3.57%4.55%3.20%-24.20%-4.58%-3.10%-3.31%-1.33%-4.09%-7.10%-1.51%
Return on Capital Employed -0.70%-0.97%-1.21%-1.87%-0.67%-0.60%-0.85%-1.17%
Return on Invested Capital -0.61%-0.86%-1.06%
Return on Assets -0.62%-0.84%-1.06%-1.56%-0.51%-0.50%-0.75%-0.87%
Return on Equity -0.59%-0.92%-1.12%